avacincapted pegol 2 MG in 0.1 ML Injection
- RxCUI
- 2645112
- RxNorm name
- avacincapted pegol 2 MG in 0.1 ML Injection
- Display name
- avacincapted pegol 2 MG in 0.1 ML Injection
- Full name
- avacincapted pegol 2 MG in 0.1 ML Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IZERVAY | AVACINCAPTAD PEGOL | Astellas Pharma US, Inc. | 1642fe6a-dc26-4d20-ae6e-654af744e3bd | 2026-02-27 | Warnings, Adverse reactions | 2645112 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1642fe6a-dc26-4d20-ae6e-654af744e3bd | avacincapted pegol 2 MG in 0.1 ML Injection | PSN | 9 | These highlights do not include all the information needed to use IZERVAY safely and effectively. See full prescribing information for IZERVAY. IZERVAY ® (avacincaptad pegol intravitreal solution) Initial U.S. Approval: 2023 | 20260227 |
| 1642fe6a-dc26-4d20-ae6e-654af744e3bd | avacincapted pegol 2 MG per 0.1 ML Injection | SY | 9 | These highlights do not include all the information needed to use IZERVAY safely and effectively. See full prescribing information for IZERVAY. IZERVAY ® (avacincaptad pegol intravitreal solution) Initial U.S. Approval: 2023 | 20260227 |
| 1642fe6a-dc26-4d20-ae6e-654af744e3bd | 0.1 ML avacincaptad pegol 20 MG/ML Injection | SCD | 9 | These highlights do not include all the information needed to use IZERVAY safely and effectively. See full prescribing information for IZERVAY. IZERVAY ® (avacincaptad pegol intravitreal solution) Initial U.S. Approval: 2023 | 20260227 |